BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28148339)

  • 1. Pharmacological Therapy for Apathy in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    Sepehry AA; Sarai M; Hsiung GR
    Can J Neurol Sci; 2017 May; 44(3):267-275. PubMed ID: 28148339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apathy in Dementia: Systematic Review of Recent Evidence on Pharmacological Treatments.
    Harrison F; Aerts L; Brodaty H
    Curr Psychiatry Rep; 2016 Nov; 18(11):103. PubMed ID: 27726067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral effects of current Alzheimer's disease treatments: a descriptive review.
    Cummings JL; Mackell J; Kaufer D
    Alzheimers Dement; 2008 Jan; 4(1):49-60. PubMed ID: 18631950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled trial of modafinil for the treatment of apathy in individuals with mild-to-moderate Alzheimer's disease.
    Frakey LL; Salloway S; Buelow M; Malloy P
    J Clin Psychiatry; 2012 Jun; 73(6):796-801. PubMed ID: 22687392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine.
    Zemek F; Drtinova L; Nepovimova E; Sepsova V; Korabecny J; Klimes J; Kuca K
    Expert Opin Drug Saf; 2014 Jun; 13(6):759-74. PubMed ID: 24845946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease.
    Schmidt R; Hofer E; Bouwman FH; Buerger K; Cordonnier C; Fladby T; Galimberti D; Georges J; Heneka MT; Hort J; Laczó J; Molinuevo JL; O'Brien JT; Religa D; Scheltens P; Schott JM; Sorbi S
    Eur J Neurol; 2015 Jun; 22(6):889-98. PubMed ID: 25808982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic treatment of apathy in dementia.
    Berman K; Brodaty H; Withall A; Seeher K
    Am J Geriatr Psychiatry; 2012 Feb; 20(2):104-22. PubMed ID: 21841459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug therapy for Alzheimer's disease].
    Shoji M
    Brain Nerve; 2010 Jul; 62(7):777-85. PubMed ID: 20675882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylphenidate and Other Pharmacologic Treatments for Apathy in Alzheimer's Disease.
    Andrade C
    J Clin Psychiatry; 2022 Feb; 83(1):. PubMed ID: 35120284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs for Alzheimer's disease.
    Cranwell-Bruce LA
    Medsurg Nurs; 2010; 19(1):51-3. PubMed ID: 20336985
    [No Abstract]   [Full Text] [Related]  

  • 11. Cholinesterase inhibitors and memantine have a role in the treatment of Alzheimer's disease.
    Rabins PV; Lyketsos CG
    Nat Clin Pract Neurol; 2006 Nov; 2(11):578-9. PubMed ID: 17057739
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials.
    Kavirajan H; Schneider LS
    Lancet Neurol; 2007 Sep; 6(9):782-92. PubMed ID: 17689146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity, significance, strengths, limitations, and evidentiary value of real-world clinical data for combination therapy in Alzheimer's disease: comparison of efficacy and effectiveness studies.
    Atri A; Rountree SD; Lopez OL; Doody RS
    Neurodegener Dis; 2012; 10(1-4):170-4. PubMed ID: 22327239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
    Beier MT
    Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylcholinesterase inhibitors and memantine in bipolar disorder: A systematic review and best evidence synthesis of the efficacy and safety for multiple disease dimensions.
    Veronese N; Solmi M; Luchini C; Lu RB; Stubbs B; Zaninotto L; Correll CU
    J Affect Disord; 2016 Jun; 197():268-80. PubMed ID: 27010579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease.
    Di Santo SG; Prinelli F; Adorni F; Caltagirone C; Musicco M
    J Alzheimers Dis; 2013; 35(2):349-61. PubMed ID: 23411693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanisms of action of Alzheimer medications].
    Alhainen K
    Duodecim; 2003; 119(20):1959-66. PubMed ID: 14640001
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease.
    Waldemar G; Gauthier S; Jones R; Wilkinson D; Cummings J; Lopez O; Zhang R; Xu Y; Sun Y; Knox S; Richardson S; Mackell J
    Int J Geriatr Psychiatry; 2011 Feb; 26(2):150-7. PubMed ID: 20597141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apathy in Alzheimer's disease: any effective treatment?
    Rea R; Carotenuto A; Fasanaro AM; Traini E; Amenta F
    ScientificWorldJournal; 2014; 2014():421385. PubMed ID: 24672318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological therapy in Alzheimer's disease. Current clinical practice in The Netherlands].
    Schölzel-Dorenbos CJ;
    Tijdschr Gerontol Geriatr; 2005 Jul; 36(3):122-6. PubMed ID: 16078659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.